CD22 and B-cell chronic lymphocytic leukemia: Another study showing that overexpressed PTPN22 positively regulates Akt activation in CLL cells by affecting the ability of Lyn to phosphorylate CD22 and recruit SHIP-1 [106] further substantiates a role for negative signals in CLL cell survival.